Perflubron
CAS No. 423-55-2
Perflubron( Perfluorooctyl bromide | PFOB )
Catalog No. M24389 CAS No. 423-55-2
Perflubron can be emulsified with egg phospholipids (EYP) and displays exceptionally fast excretion characteristics.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | 42 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePerflubron
-
NoteResearch use only, not for human use.
-
Brief DescriptionPerflubron can be emulsified with egg phospholipids (EYP) and displays exceptionally fast excretion characteristics.
-
DescriptionPerflubron can be emulsified with egg phospholipids (EYP) and displays exceptionally fast excretion characteristics. Perflubron(1-Bromoheptadecafluorooctane; Heptadecafluorooctyl bromide; Perfluorooctyl bromide) is a contrast medium for magnetic resonance imaging and sonography.
-
In Vitro——
-
In Vivo——
-
SynonymsPerfluorooctyl bromide | PFOB
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number423-55-2
-
Formula Weight498.96
-
Molecular FormulaC8BrF17
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC(C(C(C(C(F)(F)Br)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Fructo-oligosacchari...
Fructo-oligosaccharide DP11/GF10 belongs to fructooligosaccharides (FOS) with degree of polymerization (DP=11). Fructo-oligosaccharides (FOS) are composed of 10 fructose units linked by (2→1)-β-glycosidic bonds and having a single D-glucosyl unit at the non-reducing end.
-
Acrylamide monomer
Acrylamide is a member of the class of acrylamides. It has a role as a carcinogenic agent a neurotoxin a mutagen an alkylating agent and a Maillard reaction product.
-
Ac2-26 TFA
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
Cart
sales@molnova.com